Orthotopic liver transplantation for patients with hepatocellular carcinoma complicated by portal vein tumor thrombi 被引量：10

Orthotopic liver transplantation for patients with hepatocellular carcinoma complicated by portal vein tumor thrombi

下载PDF

导出

出处《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2004年第3期341-344,共4页 国际肝胆胰疾病杂志（英文版）

关键词 HEPATOCELLULAR carcinoma PORTAL VEIN TUMOR THROMBI liver transplantation

分类号 R735.7 [医药卫生—肿瘤]

引文网络
相关文献

参考文献3

1陈焕伟,甄作均,苏树英,许卓明,费凛,计勇.同种异体原位肝脏移植13例次临床经验[J].第一军医大学学报,2004,24(4):445-447. 被引量：4
2彭宝岗,罗时敏,梁力建,何强.肝细胞癌合并门静脉癌栓的外科治疗[J].中国实用外科杂志,2002,22(9):527-529. 被引量：9
3李齐根,杨广顺,卫立辛,杨宁,周学平,吴孟超.大鼠肝癌肝移植模型的建立[J].中华肝胆外科杂志,2004,10(3):191-195. 被引量：7

二级参考文献20

1Schotman SN,Van Ijken MG,Marquet RL,et al.Tumor recurrence in liver grafts: two animal models.Transplant Proc,1998,30:1052-1053. 被引量：1
2Ceriello A,Mezza F,Cozzolino S,et al.Role of immunosuppression in recurrence after liver transplantation for diethylnitrosamine-induced tumors in rats.Transpl Int,1994,7(Suppl):S204-207. 被引量：1
3Roverts JP,Liu T,Freise CE,et al.Liver transplantation improves survival of rats bearing hepatoma-3924A.J Surg Res,1996,65:59-62. 被引量：1
4Yano K,Fukuda Y,Sumimoto R,et al.Development of a rat model for orthotopic liver transplantation for hepatocellur carcinoma.Surgery,1995,118:1682-1683. 被引量：1
5Esquivel CO,Keeffe EB,Garcia G,et al.Resection versus transplantation for hepatocellular carcinoma.J Gastroenterol Hepatol,1999,14(Suppl):S37-S41. 被引量：1
6Schlitt HJ,Neipp M,Weimann A,et al.Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation.J Clin Oncol,1999,17:324-331. 被引量：1
7Suehiro T,Terashi T,Shiotani S,et al.Liver transplantation for hepatocellular carcinoma.Surgery,2002,132(Suppl):S190-S194. 被引量：1
8Matsuzaki T,Murase N,Yagihashi A,et al.Liver transplantation for diethylnitrosamine-induced hepatocellular carcinoma in rats.Transplant Proc,1992,24:748-751. 被引量：1
9Kamada N,Calne RY.A surgical experience with five hundred thirty liver transplants in the rat.Surgery,1983,93:64-69. 被引量：1
10Travis CC,McClain TW,Birkner PD.Diethylnitrosamine-induced hepatocarcinogenesis in rats: a theoretical study.Toxicol Appl Pharmacol,1991,109:289-304. 被引量：1

共引文献17

1赫军,邹全庆,梁中骁,罗建强,黄栋,刘天奇,许春梅.经皮肝穿刺门静脉灌注IL-2治疗肝癌门静脉癌栓的临床意义[J].岭南现代临床外科,2003,3(3):167-169.
2苏树英,陈焕伟,甄作均,许卓明,计勇.原位肝移植术后并发症18例临床分析[J].第一军医大学学报,2004,24(8):950-952. 被引量：2
3郑树森,徐骁,俞军,梁廷波,王伟林,沈岩,张珉,吴健,吴应盛,胡振华.肝移植治疗肝细胞癌合并门静脉癌栓的临床价值[J].中国实用外科杂志,2004,24(9):540-542. 被引量：16
4赫军,邹全庆,梁中骁,罗建强,黄栋,刘天奇,许春梅.经皮肝穿刺门静脉灌注IL-Ⅱ治疗PVTT的临床意义[J].广西医科大学学报,2003,20(4):489-490. 被引量：1
5周学平,杜隽铭,李济宇,杨勇,陆炯炯,全志伟.大鼠原位肝移植模型制作的术后稳定存活率[J].上海交通大学学报（医学版）,2006,26(6):603-606. 被引量：6
6陈颖华,蔡常洁,陆敏强,郭中敏,杨扬,陈规划.建立符合肝癌肝移植术后肝癌复发规律的大鼠模型[J].中山大学学报（医学科学版）,2006,27(6):640-643. 被引量：10
7李红春,胡宗宇,张书民,陈规划,杨扬,许赤.原位肝移植术后并发症10例报告[J].中国组织工程研究与临床康复,2007,11(25):4992-4994.
8蔡常洁,陆敏强,陈颖华,陈规划.联合免疫抑制下肝癌复发大鼠模型的建立[J].中华肝胆外科杂志,2007,13(9):624-626. 被引量：1
9陶绪雄,袁堂战,陈嘉希.腹腔镜处理腹腔镜胆囊切除术后胆漏的诊治体会[J].临床和实验医学杂志,2008,7(12):33-33. 被引量：4
10武强,李强,宋天强,任秀宝,李慧,于津浦,高春涛.肝癌肝移植术后肝癌复发大鼠模型的建立[J].肝胆胰外科杂志,2010,22(4):268-271. 被引量：2

同被引文献76

1Di-Yang Xie,Zheng-Gang Ren,Jian Zhou,Jia Fan,Qiang Gao.2019 Chinese clinical guidelines for the management of hepatocellular carcinoma: updates and insights[J].Hepatobiliary Surgery and Nutrition,2020,9(4):452-463. 被引量：85
2Jian Wu and Shu-Sen Zheng Hangzhou, China Department of Hepatobiliary Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003 , Chi- na.Liver transplantation in China: problems and their solutions[J].Hepatobiliary & Pancreatic Diseases International,2004,3(2):170-174. 被引量：15
3Shu-Sen Zheng,Ting-Bo Liang,Wei-Lin Wang,Dong-Sheng Huang,Yan Shen,Min Zhang,Xiao Xu,Ling-Jun Mou the Department of Surgery, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.Clinical experience in liver transplantation from an organ transplantation center in China[J].Hepatobiliary & Pancreatic Diseases International,2002,1(4):487-491. 被引量：5
4Chang Liu,Guang-Qin Xiao,Lu-Nan Yan,Bo Li,Li Jiang,Tian-Fu Wen,Wen-Tao Wang,Ming-Qing Xu,Jia-Yin Yang.Value of α-fetoprotein in association with clinicopathological features of hepatocellular carcinoma[J].World Journal of Gastroenterology,2013,19(11):1811-1819. 被引量：23
5Daniele Nicolini,Gianluca Svegliati-Baroni,Roberto Candelari,Cinzia Mincarelli,Alessandra Mandolesi,Italo Bearzi,Federico Mocchegiani,Andrea Vecchi,Roberto Montalti,Antonio Benedetti,Andrea Risaliti,Marco Vivarelli.Doxorubicin-eluting bead vs conventional transcatheter arterial chemoembolization for hepatocellular carcinoma before liver transplantation[J].World Journal of Gastroenterology,2013,19(34):5622-5632. 被引量：12
6郑树森.积极推进我国肝脏移植的发展[J].中华肝脏病杂志,2004,12(6):321-322. 被引量：4
7郑树森,徐骁,俞军,梁廷波,王伟林,沈岩,张珉,吴健,吴应盛,胡振华.肝移植治疗肝细胞癌合并门静脉癌栓的临床价值[J].中国实用外科杂志,2004,24(9):540-542. 被引量：16
8JiaFan JianZhou Zhi-QuanWu Shuang-JianQiu Xiao-YingWang Ying-HongShi Zhao-YouTang.Efficacy of different treatment strategies for hepatocellular carcinoma with portal vein tumor thrombosis[J].World Journal of Gastroenterology,2005,11(8):1215-1219. 被引量：65
9郑树森,徐骁,梁廷波,王伟林,沈岩,张珉,吴健,卢安卫,邵浙新.肝细胞癌肝移植89例预后分析[J].中华外科杂志,2005,43(7):450-454. 被引量：10
10樊嘉,周俭,徐泱,邱双健,吴志全,余耀,黄晓武,汤钊猷,王玉琦.肝癌肝移植适应证的选择:上海复旦标准[J].中华医学杂志,2006,86(18):1227-1231. 被引量：121

引证文献10

1Tian-Qi Liu,Jun Fan,Lin Zhou and Shu-Sen Zheng Key Laboratory of Combined Multi-organ Trans-plantation,Ministry of Public Health,Key Laboratory of Organ Trans-plantation,Zhejiang Province,and Division of Hepatobiliary and Pancreatic Surgery,Department of Surgery,State Key Laboratory for Diagnosis and Treatment of Infectious Disease,First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China,Department of Hepatobiliary Surgery,the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning 530021,China.Effects of suppressing glucose transporter-1 by an antisense oligodeoxynucleotide on the growth of human hepatocellular carcinoma cells[J].Hepatobiliary & Pancreatic Diseases International,2011,10(1):72-77. 被引量：9
2郑树森,吴健.应重视肝移植并发症的预防[J].中华医学杂志,2005,85(24):1657-1659. 被引量：14
3邵浙新,徐骁,郑树森,梁廷波,柯庆宏,马怡平.肝细胞癌患者肝移植术后甲胎蛋白的变化与肿瘤复发[J].中华普通外科杂志,2006,21(5):351-353. 被引量：21
4郑树森,吴健.肝移植治疗原发性肝癌的价值[J].中国医学科学院学报,2008,30(4):366-370. 被引量：7
5徐新保,张洪义,刘承利,张辉,肖梅,张宏义,何晓军,冯志强,赵刚.肝癌切除术后复发患者行肝移植后移植肝再发肝癌的治疗对策——一例长期存活病例报道并相关文献复习[J].空军总医院学报,2010,26(2):70-75.
6蔡秀军,朱玲华.原发性肝癌合并门静脉癌栓术后抗复发策略[J].中国实用外科杂志,2012,32(10):805-808. 被引量：3
7吴俣,张志伟.肝癌伴门静脉癌栓的外科治疗[J].肝胆胰外科杂志,2015,27(2):171-174. 被引量：2
8吕国悦.肝细胞癌合并门静脉癌栓肝移植治疗进展[J].中华消化外科杂志,2024,23(2):215-220.
9Zhao-Dan Ye,Li Zhuang,Meng-Chen Song,Zhe Yang,Wu Zhang,Jing-Feng Zhang,Guo-Hong Cao.Drug-eluting bead transarterial chemoembolization as neoadjuvant therapy pre-liver transplantation for advanced-stage hepatocellular carcinoma[J].World Journal of Gastrointestinal Oncology,2024,16(6):2476-2486.
10吴孟超,程树群,陈敏山,蔡建强,孙居仙,郭荣平,毕新宇.肝细胞肝癌合并门静脉癌栓多学科诊治中国共识(2016年版)(讨论稿)[J].肝癌电子杂志,2016,3(1):1-14. 被引量：6

二级引证文献62

1王星,刘德良,李梦倩.几种常用指标在良恶性腹水鉴别诊断中的价值[J].江西医药,2013,48(4):372-375. 被引量：1
2Zhi-Ying Feng, Jian Zhang, Sheng-Mei Zhu and Shu-Sen Zheng Department of Anesthesiology, and Department of General Surgery First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, China.Is there any difference in anesthetic management of different post-OLT stage patients undergoing nontransplant organ surgery?[J].Hepatobiliary & Pancreatic Diseases International,2006,5(3):368-373. 被引量：1
3张群华.浅论肝移植患者黄疸的处理[J].中华医学杂志,2005,85(29):2019-2020. 被引量：3
4夏伟良,谢海洋,沈岩,吴李鸣,张峰,郑树森.环孢素和他克莫司在体外对乙型肝炎病毒复制影响的对比研究[J].中华医学杂志,2006,86(2):111-115. 被引量：12
5严律南,李波,曾勇,文天夫,赵纪春,王文涛,杨家印,徐明清,马玉奎,陈哲宇,刘江文,吴宏.成人间活体右半肝肝移植24例报告[J].中华医学杂志,2006,86(6):411-415. 被引量：17
6彭承宏,王小明.应重视肝移植术后胆道并发症的防治[J].中华医学杂志,2006,86(18):1225-1226. 被引量：1
7王禾,窦科峰,杨晓剑,秦卫军,张更,于磊,康福霞,陈绍洋,熊利泽,宋振顺,刘正才.肝、胰、肾一期联合移植一例临床分析[J].中华医学杂志,2006,86(34):2421-2424. 被引量：4
8范骏,陈晓明,杨美芳,薛寒,高海女,范维薇,马伟杭,李兰娟.肝移植受者术后巨细胞病毒抗原血症的发生及其影响因素分析[J].中华医学杂志,2006,86(48):3442-3444. 被引量：1
9冯智英,张健,祝胜美,陈庆廉,郑树森.肝移植患者非移植器官手术的麻醉处理[J].中华麻醉学杂志,2006,26(12):1074-1077. 被引量：1
10徐勇,程伟,赵来源,范郁会,张刘勇,白燕,薛庆.30例原位肝移植手术临床分析[J].中国现代手术学杂志,2006,10(6):408-411.

1樊嘉,吴志全,周俭,邱双健,汤钊猷,余业勤,张博恒.肝细胞癌伴门静脉癌栓不同治疗方法的比较[J].中华肿瘤杂志,2000,22(3):247-249. 被引量：72
2Long Yang, Li-Wu Lin, Xue-Ying Lin, Shang-Da Gao, Yi-Mi He, Fa-Duan Yang, En-Sheng Xue and Xiao-Dong Lin Fuzhou, China Departments of Ultrasound and Pathology, Union Hospital, Fujian Medical University, Fuzhou 350001 , China.Ultrasound-guided fine needle aspiration biopsy in differential diagnosis of portal vein tumor thrombosis[J].Hepatobiliary & Pancreatic Diseases International,2005,4(2):234-238. 被引量：2
3胡三元,靳斌.原发性肝癌合并门静脉癌栓的治疗[J].医学新知,2008,18(5):253-255. 被引量：3
4舒琦瑾,王彬彬,朱国猛,吴良村.中西医结合治疗原发性肝癌伴门静脉癌栓16例[J].中国中医药科技,2006,13(4):274-275. 被引量：1
5周立新,严律南,王文涛,左怀全,王震侠,李晋.影响肝癌肝移植预后的主要因素和抗肿瘤治疗[J].外科理论与实践,2006,11(4):312-314.
6Jia Fan,Zhi Quan Wu,Zhao You Tang,Jian Zhou,Shuang Jian Qiu,Zeng Chen Ma,Xin Da Zhou,Sheng Long Ye Liver Cancer Institute, Zhongshan Hospital, Fudan University Medical Center (Former Shanghai University), 136 Yixueyuan Road, Shanghai 200032, China.Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein[J].World Journal of Gastroenterology,2001,7(1):28-32. 被引量：80
7施海彬,冯耀良,王杰,庄振武,李麟荪.Hepatocellular Carcinoma with Tumor Thrombus in Portal Vein: Finding in Ultrasonography, Computed Tomography, Angiography and Chemoembolization[J].The Journal of Biomedical Research,1997,21(2):32-35.
8李振洪.原发性肝癌合并门静脉癌栓的外科治疗现状[J].消化外科,2004,3(1):66-68.
9李强,郝希山,张忠国,宋天强,郝继辉,马维东,孙涛,王殿昌.门静脉灌注化疗治疗肝癌伴门静脉瘤栓的临床价值[J].中华肝胆外科杂志,2002,8(7):420-421. 被引量：6
10黎洪浩,陈积圣,李海刚,吴一冲.肝切除联合经导管化学药物治疗伴有门静脉癌栓的肝癌40例报告[J].中华普通外科杂志,2001,16(8):457-459. 被引量：4

Hepatobiliary & Pancreatic Diseases International

2004年第3期

浏览历史

内容加载中请稍等...